Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof

Details for Australian Patent Application No. 2002243323 (hide)

Owner The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services TorreyPines Therapeutics, Inc.

Inventors Powers, Gordon; Soncrant, Timothy T; Greig, Nigel H; Ingram, Donald S; Davidson, Diane; Holloway, Harold W; Sturgess, Michael; Yu, Qiang-Sheng; Brossi, Arnold; Giordano, Anthony; Utsuki, Tada; Shaw, Karen T Y

Agent Griffith Hack

Pub. Number AU-B-2002243323

PCT Pub. Number WO02/48150

Priority 60/245,329 02.11.00 US

Filing date 2 November 2001

Wipo publication date 24 June 2002

Acceptance publication date 12 July 2007

International Classifications

C07D 209/16 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

C07D 209/34 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

C07D 491/04 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

C07D 495/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

C07D 498/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

10 June 2004 Amendment Made

  The nature of the amendment is: Add the name of the coapplicant Message Pharmaceuticals, Inc.

6 April 2006 Assignment before Grant

  The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services; Message Pharmaceuticals, Inc. The application has been assigned to The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services; Message Pharmaceuticals, Inc.; Brossi, Arnold; Soncrant, Timothy

12 July 2007 Assignment before Grant

  Message Pharmaceuticals, Inc.; The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services; Brossi, Arnold; Soncrant, Timothy T. The application has been assigned to The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services; TorreyPines Therapeutics, Inc.

12 July 2007 Application Accepted

  Published as AU-B-2002243323

8 November 2007 Standard Patent Sealed

24 January 2008 Corrigenda

  Applications Accepted - Name Index Under the names The Government of the United States of America, as represented by the Secretary Department of Health and Human Services and TorreyPines Therapeutics, Inc., Application No. 2002243323, under INID (54), correct the title to read Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002243324-8-(AMINOALKOXYMINO)-8H-DIBENZ O(a,e)TRIAZOLO(4,5-c)CYCLOHEPTE NES AS GROWTH HORMONE SECRETAGOGUES

2002243322